We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$250M
AUM Growth
-$3.21M
Cap. Flow
-$9.77M
Cap. Flow %
-3.9%
Top 10 Hldgs %
39.19%
Holding
61
New
2
Increased
2
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$2.26M
2
XLNX
Xilinx Inc
XLNX
+$1.81M
3
ADI icon
Analog Devices
ADI
+$1.76M
4
NYT icon
New York Times
NYT
+$1.65M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$2.97M
2
WBA
Walgreens Boots Alliance
WBA
+$2.68M
3
PG icon
Procter & Gamble
PG
+$2.53M
4
IPGP icon
IPG Photonics
IPGP
+$1.81M
5
BMY icon
Bristol-Myers Squibb
BMY
+$1.47M

Sector Composition

Rank Sector Weight
1 Healthcare 26.32%
2 Industrials 19.26%
3 Technology 18.3%
4 Communication Services 9.29%
5 Financials 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTV icon
26
Fortive
FTV
$18.8B
$4.49M 1.79%
92,342
– –
AVGO icon
27
Broadcom
AVGO
$1.76T
$4.45M 1.78%
183,350
– –
ILMN icon
28
Illumina
ILMN
$28.2B
$4.41M 1.76%
16,242
– –
SJM icon
29
J.M. Smucker
SJM
$12B
$4.26M 1.7%
39,650
– –
PFE icon
30
Pfizer
PFE
$143B
$4.06M 1.62%
118,044
-7,641
-6% -$261K
RTN
31
DELISTED
Raytheon Company
RTN
$3.86M 1.54%
20,000
– –
CL icon
32
Colgate-Palmolive
CL
$74.4B
$3.32M 1.33%
51,200
– –
LOW icon
33
Lowe's Companies
LOW
$117B
$3.31M 1.32%
34,600
– –
SYK icon
34
Stryker
SYK
$123B
$3.23M 1.29%
19,145
– –
WMT icon
35
Walmart Inc
WMT
$909B
$2.83M 1.13%
99,000
– –
TDOC icon
36
Teladoc Health
TDOC
$1.7B
$2.69M 1.08%
+46,345
New +$2.26M
CMCSA icon
37
Comcast
CMCSA
$85B
$2.56M 1.02%
78,000
– –
GOOG icon
38
Alphabet (Google) Class C
GOOG
$4.22T
$2.52M 1.01%
45,120
– –
PRGO icon
39
Perrigo
PRGO
$1.48B
$2.3M 0.92%
31,565
– –
PEP icon
40
PepsiCo
PEP
$187B
$2.29M 0.91%
21,000
– –
ADBE icon
41
Adobe
ADBE
$94.3B
$2.19M 0.88%
9,000
– –
CSX icon
42
CSX Corp
CSX
$94.3B
$2.17M 0.87%
102,000
-60,000
-37% -$1.24M
ZTS icon
43
Zoetis
ZTS
$32.1B
$2.11M 0.84%
24,818
– –
ESRX
44
DELISTED
Express Scripts Holding Company
ESRX
$1.85M 0.74%
24,000
– –
NYT icon
45
New York Times
NYT
$12.3B
$1.81M 0.72%
+70,000
New +$1.65M
DD icon
46
DuPont de Nemours
DD
$18.3B
$1.69M 0.68%
10,125
– –
T icon
47
AT&T
T
$152B
$1.28M 0.51%
52,960
-53,239
-50% -$1.34M
IFF icon
48
International Flavors & Fragrances
IFF
$20B
$1.24M 0.5%
10,000
– –
GILD icon
49
Gilead Sciences
GILD
$167B
$1.1M 0.44%
15,500
– –
BIIB icon
50
Biogen
BIIB
$30.4B
$1.03M 0.41%
3,550
– –
1
2
3

Similar funds

RC
RBO & Co Saint Helena, California $620M AUM 4.67% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $620M AUM 16.24% 1-Year Est. Return
KFAS
Keating Financial Advisory Services Manhattan, Kansas $619M AUM
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
RIS
Richmond Investment Services Mequon, Wisconsin $619M AUM 22.39% 1-Year Est. Return
AMG
Asset Management Group Stamford, Connecticut $619M AUM 15.97% 1-Year Est. Return
BWP
Burling Wealth Partners Chicago, Illinois $618M AUM 17.33% 1-Year Est. Return
MC
McMorgan & Co San Francisco, California $618M AUM 8.76% 1-Year Est. Return

Chad R. Baker's Q2 2018 Portfolio in Review

As of Q2 2018, Chad R. Baker held 61 positions worth $250M, down 1.3% from $253M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Chad R. Baker withdrew a net $9.77M in Q2 2018, closing 6 positions and reducing 7 holdings. Its most notable exit was CVS Health, an estimated $2.97M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Technology.

Against the trend, Chad R. Baker opened a new position in Teladoc Health worth $2.69M.

  • Chad R. Baker's largest Q2 2018 buy was Teladoc Health: 46,345 shares worth $2.69M.
  • Chad R. Baker added most to Xilinx Inc in Q2 2018, an estimated $1.81M increase.
  • Chad R. Baker's biggest Q2 2018 reduction was Procter & Gamble, cutting an estimated $2.53M.
  • Chad R. Baker fully exited CVS Health in Q2 2018, selling an estimated $2.97M.
  • Chad R. Baker's ten largest holdings make up 39% of its $250M portfolio in Q2 2018.
  • Chad R. Baker opened 2 new positions and closed 6 in Q2 2018.
  • Chad R. Baker's portfolio value fell 1.3% quarter-over-quarter to $250M.

Based on Chad R. Baker's 13F filing for Q2 2018, filed 13 Aug 2018.